Human Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 ...
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic sa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback